Wednesday, Aug 05, 2020 | Last Update : 05:18 AM IST

133rd Day Of Lockdown

Maharashtra45795629935616142 Tamil Nadu2682852087844349 Andhra Pradesh176333956251604 Karnataka145830692722704 Delhi1391561252264033 Uttar Pradesh100310572711817 West Bengal80984568841785 Telangana6894649675563 Gujarat65704485612529 Bihar6203140760349 Assam4816233429115 Rajasthan4667932832732 Haryana3779631226448 Odisha3768124483258 Madhya Pradesh3508225414912 Kerala279561629988 Jammu and Kashmir2239614856417 Punjab1901512491462 Jharkhand140705199129 Chhatisgarh10109761369 Uttarakhand8008484795 Goa7075511460 Tripura5520367528 Puducherry4147253758 Manipur301818147 Himachal Pradesh2879171013 Nagaland24056594 Arunachal Pradesh179011053 Chandigarh120671520 Meghalaya9173305 Sikkim7832971 Mizoram5022820
  World   Africa  11 Jul 2020  Most adults infected with COVID-19 in South Africa are asymptomatic cases

Most adults infected with COVID-19 in South Africa are asymptomatic cases

PTI
Published : Jul 11, 2020, 8:51 am IST
Updated : Jul 11, 2020, 8:51 am IST

Majority of COVID-19 infections are going unnoticed, but enrolment process for vaccine trials has shown that far more people are infected

 A man looks into a tent as a health worker in protective gear collects a sample for COVID-19 testing in Diepsloot, Johannesburg, South Africa. (AP)
  A man looks into a tent as a health worker in protective gear collects a sample for COVID-19 testing in Diepsloot, Johannesburg, South Africa. (AP)

Johannesburg: Of all adults infected with COVID-19 in South Africa, 50 to 66 per cent are asymptomatic cases, with many infections going undetected, a health official has claimed.

The coronavirus, which first emerged in China's Wuhan city, has claimed 3,860 lives in South Africa with over 2,50,000 confirmed cases.

 

“The majority of COVID-19 infections are going unnoticed,” said Dr Shabir Mahdi, who is heading the University of Oxford's vaccine trials in South Africa.

In an interview with CNBC on Friday, Mahdi said the high number of asymptomatic cases was causing difficulties in vaccine trials.

The enrolment process has shown that far more people are asymptomatic than what was previously believed, Mahdi said.

He estimated that only about 10 per cent of all COVID-19 cases are being officially reported.

Mahdi said around 80 per cent of all children who are infected are asymptomatic.

The clinical trials require people who have not been infected by the virus. Part of the enrolment process for the COVID-19 vaccine trial involves the screening of individuals.

 

Qualifying participants are randomly allocated into one of two groups -- vaccine group or placebo group.

Mahdi said the results on whether the vaccine works as protection against COVID-19 would be available by the end of November this year, but the trials may be extended into the second quarter of next year.

He warned against 'undue' optimism, reminding that only 10 per cent of vaccines that go into clinical trials are eventually licensed for use.

“Right now there are approximately 200 vaccines that are being developed (around the world) for COVID-19,” he said.

“It would be a huge accomplishment if, over the next 12 to 18 months, we are successful in showing that even one out of every 20 of the vaccines that go into human studies are safe and provide some protection against COVID-19,” he said.

 

Mahdi said for the next year at least the only reliable protection against COVID-19 would be the non-pharmaceutical interventions of handwashing, sanitisation and social distancing.

Tags: south africa, coronavirus, covid-19, clinical trials, vaccine trials